Conference Coverage

Researchers propose new risk groups for NK-AML

NEWPORT BEACH, CALIF. – Investigators used machine learning algorithms to risk stratify patients with normal karyotype acute myeloid leukemia.

Conference Coverage

Back to the drawing board for MPN combo

NEWPORT BEACH, CALIF. – Ruxolitinib plus decitabine won’t proceed to a phase 3 trial for the treatment of accelerated or blast phase...